Abstract
Group B streptococcus (GBS) is a common cause of infections in pregnant females and non-pregnant adults with chronic diseases (such as diabetes and cancer), also it is the main reason of septicaemia and meningitis in infants. The aim of this study was to figure out how common GBS is in pregnant women, the antimicrobial sensitivity pattern of the isolated GBS colonies and check the presence of scpB and rib virulence genes in these isolates. We screened 203 pregnant women attending the Maternity Hospital of Ain Shams University using vaginal sampling. Isolation was done on CHROMagarTM Strep B and sheep blood agar plates then identified via colony characters, Gram stain, test for catalase production, Christie–Atkins–Munch-Petersen (CAMP) test, test for hippurate hydrolysis and latex agglutination test. This was followed by an antibiotic susceptibility test. Finally, Detection of scpB and rib virulence genes by conventional PCR was done. Our study detected that the prevalence rate of GBS in involved pregnant women was 11.33%. A statistically significant association between colonization and history of spontaneous abortion and preterm labor was observed. CHROMagar™ StrepB showed the same sensitivity of sheep blood agar with extensive effort to isolate suspected GBS colonies from blood agar. GBS was 100% sensitive to levofloxacin, linezolid, cefepime, ceftaroline and ceftriaxone. Also, it was highly sensitive to vancomycin (91.3%). Sensitivity to clindamycin, azithromycin, penicillin and ampicillin was (21.70%, 21.70%,47.80%, 47.80%) respectively. The least sensitivity of GBS was to erythromycin ( 8.7%). All isolates possessed the scpB gene (100%) while only 18 isolates (78.26%) had the rib gene.
Publisher
Journal of Pure and Applied Microbiology
Subject
Applied Microbiology and Biotechnology,Microbiology,Biotechnology
Reference71 articles.
1. 1. Spellerberg B. Pathogenesis of neonatal Streptococcus agalactiae infections. Microbes Infect. 2000;2(14):1733-1742. doi: 10.1016/S1286-4579(00)01328-9
2. 2. Edwards MS, Nizet V, Baker CJ. Group B Streptococcal Infections. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington JS, Klein JO, Wilson CB, et al (Eds), Elsevier Saunders, Philadelphia. 2011:419. doi: 10.1016/B978-1-4160-6400-8.00012-2
3. 3. Schuchat A. Epidemiology of Group B Streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11(3):497-513. doi: 10.1128/CMR.11.3.497
4. 4. Capan M, Mombo-Ngoma G , Akerey-Diop D, et al. Epidemiology and management of group B streptococcal colonization during pregnancy in Africa. Wien Klin Wochenschr. 2012;124(Suppl 3):14-16. doi: 10.1007/s00508-012-0239-5
5. 5. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease , Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep. 2010;59(10):1-36.